Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 45% ± 11% | |
epithelial cell | 3 studies | 25% ± 6% | |
glutamatergic neuron | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 338.30 | 245 / 245 | 100% | 4.99 | 501 / 502 |
brain | 100% | 670.52 | 2642 / 2642 | 100% | 5.25 | 702 / 705 |
liver | 100% | 25240.16 | 226 / 226 | 100% | 107.31 | 404 / 406 |
thymus | 100% | 313.31 | 651 / 653 | 99% | 3.39 | 601 / 605 |
adrenal gland | 100% | 310.88 | 258 / 258 | 94% | 2.63 | 217 / 230 |
breast | 100% | 259.75 | 459 / 459 | 92% | 3.15 | 1032 / 1118 |
ovary | 100% | 273.38 | 180 / 180 | 90% | 2.54 | 387 / 430 |
bladder | 100% | 297.86 | 21 / 21 | 87% | 3.23 | 438 / 504 |
uterus | 100% | 256.65 | 170 / 170 | 86% | 2.89 | 396 / 459 |
pancreas | 99% | 199.83 | 326 / 328 | 85% | 1.88 | 152 / 178 |
intestine | 99% | 227.57 | 957 / 966 | 83% | 3.61 | 436 / 527 |
stomach | 99% | 204.82 | 356 / 359 | 83% | 2.93 | 236 / 286 |
skin | 100% | 229.21 | 1800 / 1809 | 82% | 2.59 | 386 / 472 |
kidney | 100% | 327.98 | 89 / 89 | 80% | 1.79 | 722 / 901 |
lung | 96% | 166.38 | 552 / 578 | 80% | 2.21 | 928 / 1155 |
esophagus | 99% | 216.79 | 1437 / 1445 | 62% | 1.77 | 114 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 5.06 | 29 / 29 |
spleen | 100% | 220.07 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.57 | 1 / 1 |
blood vessel | 100% | 276.36 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 190.80 | 1195 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 3.31 | 79 / 80 |
heart | 90% | 133.36 | 772 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 3.18 | 37 / 45 |
muscle | 59% | 62.87 | 470 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 44% | 147.10 | 407 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0006642 | Biological process | triglyceride mobilization |
GO_0000038 | Biological process | very long-chain fatty acid metabolic process |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0015911 | Biological process | long-chain fatty acid import across plasma membrane |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0044539 | Biological process | long-chain fatty acid import into cell |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0046951 | Biological process | ketone body biosynthetic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005324 | Molecular function | long-chain fatty acid transmembrane transporter activity |
GO_0015245 | Molecular function | fatty acid transmembrane transporter activity |
GO_0031957 | Molecular function | very long-chain fatty acid-CoA ligase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
GO_0047747 | Molecular function | cholate-CoA ligase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC27A5 |
Protein name | Long-chain fatty acid transport protein 5 (FATP-5) (Fatty acid transport protein 5) (Bile acid-CoA ligase) (BA-CoA ligase) (BAL) (Bile acyl-CoA synthetase) (BACS) (EC 6.2.1.7) (Cholate--CoA ligase) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2) (VLCS-H2) (VLCSH2) (EC 6.2.1.-) (Very long-chain acyl-CoA synthetase-related protein) (VLACS-related) (VLACSR) long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) |
Synonyms | ACSB FATP5 ACSVL6 FACVL3 |
Description | FUNCTION: May mediate the import of long-chain fatty acids (LCFA) by facilitating their transport across cell membranes . Also catalyzes the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates . Mainly functions as a bile acyl-CoA synthetase catalyzing the activation of bile acids via ATP-dependent formation of bile acid CoA thioesters which is necessary for their subsequent conjugation with glycine or taurine . Both primary bile acids (cholic acid and chenodeoxycholic acid) and secondary bile acids (deoxycholic acid and lithocholic acid) are the principal substrates . In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate ((25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate or THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol . Plays an important role in hepatic fatty acid uptake and bile acid reconjugation and recycling but not in de novo synthesis of bile acids (By similarity). . |
Accessions | Q9Y2P5 ENST00000601355.1 [Q9Y2P5-2] ENST00000594786.1 ENST00000595851.5 M0R075 ENST00000263093.7 [Q9Y2P5-1] |